Related Experiment Video
Updated: Jul 7, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
[Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy]
M E Hendriks1, D J van Westerloo, P Portegies
1Onze Lieve Vrouwe Gasthuis, Amsterdam. m.e.hendriks@amc.uva.nl
Hepatic encephalopathy, a reversible neurological condition, can manifest as confusion. Early diagnosis and treatment, like lactulose for ammonia toxicity, are crucial for patient recovery and survival.
Area of Science:
- Hepatology
- Neurology
- Internal Medicine
Background:
- Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome associated with liver dysfunction.
- It presents with a spectrum of neurological and psychiatric symptoms, often reversible with appropriate management.
- The exact pathophysiology is not fully elucidated, but ammonia toxicity is considered a key factor.
Observation:
- This case series describes three patients with liver failure who developed hepatic encephalopathy.
- Two patients with chronic liver disease experienced confusion and improved with lactulose treatment.
- A third patient with acute autoimmune hepatitis and liver failure progressed to coma and unfortunately succumbed.
Findings:
- Hepatic encephalopathy can be challenging to diagnose, particularly in its early stages, presenting as subtle cognitive impairment or distinct neurological episodes.
- While ammonia levels and EEG findings can support the diagnosis, HE is primarily a clinical diagnosis.
- Underlying conditions like infection or gastrointestinal bleeding frequently precipitate HE episodes.
Implications:
- Early recognition and prompt treatment of hepatic encephalopathy and its underlying causes are vital for reducing patient morbidity and mortality.
- Lactulose therapy demonstrated efficacy in managing HE in patients with chronic liver disease.
- The case highlights the critical need for timely intervention in acute liver failure to prevent fatal outcomes.
Related Concept Videos
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

